Advertisement
Canada Markets open in 2 hrs 26 mins
  • S&P/TSX

    22,375.83
    +116.63 (+0.52%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • DOW

    39,387.76
    +331.36 (+0.85%)
     
  • CAD/USD

    0.7309
    -0.0003 (-0.0351%)
     
  • CRUDE OIL

    79.93
    +0.67 (+0.85%)
     
  • BTC-CAD

    86,221.45
    +3,006.35 (+3.61%)
     
  • CMC Crypto 200

    1,304.37
    -53.64 (-3.95%)
     
  • GOLD FUTURES

    2,382.30
    +42.00 (+1.79%)
     
  • RUSSELL 2000

    2,073.63
    +18.49 (+0.90%)
     
  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     
  • NASDAQ futures

    18,289.50
    +75.00 (+0.41%)
     
  • VOLATILITY

    12.79
    +0.10 (+0.79%)
     
  • FTSE

    8,448.77
    +67.42 (+0.80%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6779
    +0.0001 (+0.01%)
     

Behind Valeant’s Branded Drugs: Other 3Q17 Performances

In 3Q17, Valeant's (VRX) Arestin reported revenues of $26 million, which was ~7% lower on a YoY (year-over-year) basis and 7% lower quarter-over-quarter.